Effect of PCSK9 Inhibitors on Coronary Atherosclerotic Plaques Derived From Optical Coherence Tomography

A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 396 participants.

Also called NCT06520904

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 396 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT06520904
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT06520904. Randomized; no masking; primary purpose treatment. Start 2024-07-01 (actual); primary completion 2026-09-30 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Effect of PCSK9 Inhibitors on Coronary Atherosclerotic Plaques Derived From Optical Coherence Tomography
Condition
Optical Coherence Tomography
Intervention (Drug)
PCSK9 inhibitor
Intervention (Drug)
Statin
Lead sponsor
First Affiliated Hospital of Xinjiang Medical University (class: other)

Record details

Record id
cardio:ct-nct06520904
Content hash
c327d2399116e9eca7cc529b4c458adc69078161970ecbc9c0669ad693f21fbf